Clinical trials
Terminated Schizophrenia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre for Addiction and Mental Health | 3 |
| Boehringer Ingelheim | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| ACADIA Pharmaceuticals Inc. | 1 |
| Amgen | 1 |
| Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec | 1 |
| Janssen-Ortho Inc., Canada | 1 |
| Lundbeck Canada Inc. | 1 |
| Medicure | 1 |
| Nova Scotia Health Authority | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 21 |
| Psychotic Disorders | 7 |
| Metabolic Syndrome | 2 |
| Agnosia | 1 |
| Body Weight Changes | 1 |
| Hypersensitivity | 1 |
| Obesity | 1 |
| Schizophrenia Spectrum and Other Psychotic Disorders | 1 |
| Schizophrenia, Paranoid | 1 |
| Tardive Dyskinesia | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.